Biblio

Export 3166 results:
Author Title [ Type(Desc)] Year
Journal Article
E. Dorey, Bamji-Mirza, M., Najem, D., Li, Y., Liu, H., Callaghan, D., Walker, D., Lue, L. - F., Stanimirovic, D., and Zhang, W., “Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1265-1279, 2017.
S. K. Singhrao, Harding, A., Chukkapalli, S., Olsen, I., Kesavalu, L., and Crean, S. J., “Apolipoprotein E Related Co-Morbidities and Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 935-48, 2016.
M. Basta, Zaganas, I., Simos, P., Koutentaki, E., Dimovasili, C., Mathioudakis, L., Bourbouli, M., Panagiotakis, S., Kapetanaki, S., and Vgontzas, A., “Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.”, J Alzheimers Dis, vol. 79, no. 2, pp. 763-771, 2021.
T. Persson, Lattanzio, F., Calvo-Garrido, J., Rimondini, R., Rubio-Rodrigo, M., Sundström, E., Maioli, S., Sandebring-Matton, A., and Cedazo-Minguez, A., “Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis.”, J Alzheimers Dis, vol. 56, no. 2, pp. 601-617, 2017.
L. Calderón-Garcidueñas and de la Monte, S. M., “Apolipoprotein E4, Gender, Body Mass Index, Inflammation, Insulin Resistance, and Air Pollution Interactions: Recipe for Alzheimer's Disease Development in Mexico City Young Females.”, J Alzheimers Dis, vol. 58, no. 3, pp. 613-630, 2017.
Y. Ling Chai, Yeo, H. Kai- Hui, Wang, J., Hilal, S., Ikram, M. Kamran, Venketasubramanian, N., Wong, B. - S., and Chen, C. Li- Hsian, “Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1111-8, 2016.
C. J. Smith and J Ashford, W., “Apolipoprotein ɛ4-Associated Protection Against Pediatric Enteric Infections is a Survival Advantage in Pre-Industrial Populations.”, J Alzheimers Dis, vol. 93, no. 3, pp. 907-918, 2023.
N. Nakamura, Ohyagi, Y., Imamura, T., Yanagihara, Y. T., Iinuma, K. M., Soejima, N., Murai, H., Yamasaki, R., and Kira, J. - I., “Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1151-1161, 2017.
F. Sellal, Wallon, D., Martinez-Almoyna, L., Marelli, C., Dhar, A., Oesterlé, H., Rovelet-Lecrux, A., Rousseau, S., Kourkoulis, C. E., Rosand, J., DiPucchio, Z. Y., Frosch, M., Gombert, C., Audoin, B., Miné, M., Riant, F., Frebourg, T., Hannequin, D., Campion, D., Greenberg, S. M., Tournier-Lasserve, E., and Nicolas, G., “APP Mutations in Cerebral Amyloid Angiopathy with or without Cortical Calcifications: Report of Three Families and a Literature Review.”, J Alzheimers Dis, vol. 56, no. 1, pp. 37-46, 2017.
T. B. Shea and Remington, R., “Apparent Cognitive Decline as Revealed by an Executive Function Test within a Cohort of Elderly Individuals Self-Reporting Normal Cognitive Performance.”, J Alzheimers Dis, vol. 61, no. 3, pp. 913-915, 2018.
H. - F. Wang, Tan, L., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Liu, Y., Wang, C., Tsai, R. M., Jia, J. - P., and Yu, J. - T., “Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.”, J Alzheimers Dis, vol. 51, no. 1, pp. 227-36, 2016.
J. - W. Liang, Fang, Z. - Y., Huang, Y., Liuyang, Z. - Y., Zhang, X. - L., Wang, J. - L., Wei, H., Wang, J. - Z., Wang, X. - C., Zeng, J., and Liu, R., “Application of Weighted Gene Co-Expression Network Analysis to Explore the Key Genes in Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1353-1364, 2018.
J. Rosenberg, “Approaches to Increasing Ethical Compliance in China with Drug Trial Standards of Practice.”, J Alzheimers Dis, vol. 52, no. 3, pp. 825-7, 2016.
J. Yang, Zhang, R., Shi, C., Mao, C., Yang, Z., Suo, Z., Torp, R., and Xu, Y., “AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 157-169, 2017.
C. Yang, Huang, X., Huang, X., Mai, H., Li, J., Jiang, T., Wang, X., and Lü, T., “Aquaporin-4 and Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 2, pp. 391-402, 2016.
S. Ben Jemaa, Romdhane, N. Attia, Bahri-Mrabet, A., Jendli, A., Le Gall, D., and Bellaj, T., “An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.”, J Alzheimers Dis, vol. 60, no. 1, pp. 11-21, 2017.
J. C. de la Torre, “Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations.”, J Alzheimers Dis, vol. 57, no. 2, pp. 353-371, 2017.
M. José Gil, Manzano, M. Sagrario, Cuadrado, M. Luz, Fernández, C., Góméz, E., Matesanz, C., Calero, M., and Rábano, A., “Argyrophilic Grain Pathology in Frontotemporal Lobar Degeneration: Demographic, Clinical, Neuropathological, and Genetic Features.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1109-1117, 2018.
E. Grossi, Stoccoro, A., Tannorella, P., Migliore, L., and Coppedè, F., “Artificial Neural Networks Link One-Carbon Metabolism to Gene-Promoter Methylation in Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1517-22, 2016.
J. A. Snir, Suchy, M., Bindseil, G. A., Kovacs, M., Chronik, B. A., Hudson, R. H. E., Pasternak, S. H., and Bartha, R., “An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1241-1252, 2018.
P. Ding, Gorenflo, M. P., Zhu, X., and Xu, R., “Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study.”, J Alzheimers Dis, vol. 92, no. 3, pp. 989-1000, 2023.
C. - C. Yang, Chiu, M. - J., Chen, T. - F., Chang, H. - L., Liu, B. - H., and Yang, S. - Y., “Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1323-1332, 2018.
S. C. Mallo, Ismail, Z., Pereiro, A. X., Facal, D., Lojo-Seoane, C., Campos-Magdaleno, M., and Juncos-Rabadán, O., “Assessing Mild Behavioral Impairment with the Mild Behavioral Impairment-Checklist in People with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 66, no. 1, pp. 83-95, 2018.
F. Jesus Martinez-Murcia, Górriz, J. Manuel, Ramírez, J., Segovia, F., Salas-Gonzalez, D., Castillo-Barnes, D., and Ortiz, A., “Assessing Mild Cognitive Impairment Progression using a Spherical Brain Mapping of Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 65, no. 3, pp. 713-729, 2018.
N. Schwab and Hazrati, L. - N., “Assessing the Limitations and Biases in the Current Understanding of Chronic Traumatic Encephalopathy.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1067-1076, 2018.

Pages